Compare RLMD & DIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RLMD | DIN |
|---|---|---|
| Founded | 2004 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 348.8M | 378.8M |
| IPO Year | 2012 | 1994 |
| Metric | RLMD | DIN |
|---|---|---|
| Price | $3.06 | $37.22 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 6 |
| Target Price | $10.75 | ★ $35.67 |
| AVG Volume (30 Days) | ★ 1.7M | 566.8K |
| Earning Date | 11-12-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 2.05% |
| EPS Growth | ★ 45.28 | N/A |
| EPS | N/A | ★ 1.29 |
| Revenue | $13,070.00 | ★ $879,300,000.00 |
| Revenue This Year | N/A | $11.39 |
| Revenue Next Year | N/A | $2.63 |
| P/E Ratio | ★ N/A | $28.75 |
| Revenue Growth | ★ 154.83 | 8.25 |
| 52 Week Low | $3.07 | $24.46 |
| 52 Week High | $8.00 | $39.68 |
| Indicator | RLMD | DIN |
|---|---|---|
| Relative Strength Index (RSI) | 37.32 | 65.15 |
| Support Level | N/A | $33.10 |
| Resistance Level | $3.55 | N/A |
| Average True Range (ATR) | 0.43 | 1.54 |
| MACD | -0.04 | 0.03 |
| Stochastic Oscillator | 4.05 | 86.70 |
Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.
Dine Brands Global Inc owns and franchises thousands of restaurants under the International House of Pancakes (IHOP), Applebee's Neighborhood Grill + Bar (Applebee's), and the Fuzzy's Taco Shop (Fuzzy's) names. The company conducts its business through three reportable segments: Franchise, Company-owned restaurants, and Rental. The majority of its revenue is generated from the Franchise segment, which consists of IHOP, Applebee's, and Fuzzy's franchise operations and generates revenue mainly from royalties and advertising fees from several IHOP, Applebee's, and Fuzzy's franchised restaurants, in addition to revenues from the sale of proprietary IHOP and Fuzzy's products to its franchisees. Geographically, the majority of the company's revenues is generated from its domestic market.